<SEC-DOCUMENT>0000950103-25-015313.txt : 20251126
<SEC-HEADER>0000950103-25-015313.hdr.sgml : 20251126
<ACCEPTANCE-DATETIME>20251126135341
ACCESSION NUMBER:		0000950103-25-015313
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251126
DATE AS OF CHANGE:		20251126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251528288

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251528289

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237978_424b2-us2524900d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 67%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Filed
    Pursuant to Rule 424(b)(2)</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; color: #888888"><FONT STYLE="font-size: 9pt"><B>Registration
    Statement Nos. 333-270327 and 333-270327-01</B></FONT></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 76%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>November 24, 2025</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Medium-Term Senior
    Notes, Series N </B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888888"><FONT STYLE="font-size: 9pt"><B>Pricing Supplement
    No. 2025-USNCH29142 to Product Supplement No. EA-09-02<BR>
    dated March 23, 2023, Underlying Supplement No. 11 dated March 7, 2023 and<BR>
    Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></P></TD>
    <TD STYLE="white-space: nowrap; width: 24%; font-size: 12pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><IMG SRC="image_001.jpg" ALT="citi_logo_Blue" STYLE="height: 65px; width: 94px"></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; text-align: justify; color: #BB0826"><B>Citigroup Global
Markets Holdings Inc.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; text-align: justify; color: #BB0826"><B>All Payments
Due from Citigroup Global Markets Holdings Inc. Fully and Unconditionally Guaranteed by Citigroup Inc.</B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside
Participation to a Cap and Principal Return at Maturity</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.4pt 0pt 0; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP>
due November 29, 2029&nbsp;&nbsp; </B></P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.5pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
to the Nasdaq-100 Index<SUP>&reg;</SUP> (the &ldquo;underlying&rdquo;) </FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
ordinary debt securities, the notes do not pay interest.&nbsp;Instead, the notes provide for a maturity payment amount that may be greater
than or equal to the stated principal amount of the notes, depending on the performance of the underlying from the starting value to
the ending value, subject to the maximum return. The maturity payment amount will reflect the following terms:</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 35.75pt; text-align: justify; text-indent: -13.95pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
the ending value is greater than the starting value, you will receive the stated principal amount plus a positive return equal to 100%
of the percentage increase in the value of the underlying from the starting value, subject to a maximum return of 21.00% of the stated
principal amount</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 35.75pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
the ending value is less than or equal to the starting value, you will be repaid the stated principal amount but will not receive any
positive return on your investment</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Repayment
of principal at maturity regardless of underlying performance (subject to issuer credit risk)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;All
payments on the notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.; if Citigroup Global
Markets Holdings Inc. and Citigroup Inc. default on their obligations, you could lose some or all of your investment</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
periodic interest payments or dividends</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 22.25pt; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;The
notes will not be listed on any securities exchange and, accordingly, may have limited or no liquidity.&nbsp;&nbsp;You should not invest
in the notes unless you are willing to hold them to maturity.</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes have complex features and investing
in the notes involves risks not associated with an investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo;
beginning on page PS-6 and &ldquo;Risk Factors&rdquo; beginning on page PS-5 of the accompanying product supplement and beginning on
page S-1 of the accompanying prospectus supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the notes or determined that this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes are unsecured debt obligations issued
by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc.&nbsp;&nbsp;All payments due on the notes are subject to the
credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.&nbsp;&nbsp;None of Wells Fargo Securities, LLC (&ldquo;Wells
Fargo&rdquo;) or any of its affiliates will have any liability to the purchasers of the notes in the event Citigroup Global Markets Holdings
Inc. defaults on its obligations under the notes and Citigroup Inc. defaults on its guarantee obligations.&nbsp;&nbsp;The notes are not
bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are
they obligations of, or guaranteed by, a bank.</B></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; width: 54%; border-bottom: white 1pt solid; border-right: white 1pt solid">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 22%; border-bottom: Black 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Per Note</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 24%; border-bottom: Black 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Total</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Public Offering Price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$530,000.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Underwriting Discount and Commission<SUP>(2)(3)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$38.30</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$20,299.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Proceeds to Citigroup Global Markets Holdings Inc.<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$961.70</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$509,701.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(1) On the date of
this pricing supplement, the estimated value of the notes is $939.90 per note, which is less than the public offering price.&nbsp;&nbsp;The
estimated value of the notes is based on Citigroup Global Markets Inc.&rsquo;s (&ldquo;CGMI&rdquo;) proprietary pricing models and our
internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price,
if any, at which any person may be willing to buy the notes from you at any time after issuance.&nbsp;&nbsp;See &ldquo;Valuation of the
Notes&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(2) CGMI, an affiliate
of Citigroup Global Markets Holdings Inc., as the lead agent for the offering, has agreed to sell the notes to Wells Fargo, as agent.
Wells Fargo will receive an underwriting discount and commission of 3.83% ($38.30) for each note it sells. Wells Fargo may pay selected
dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;) (the trade name of the retail brokerage business of its affiliates,
Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), a fixed selling commission of 2.75% ($27.50) for
each note they sell.&nbsp;&nbsp;In addition to the selling commission allowed to WFA, Wells Fargo may pay $0.75 per note of the underwriting
discount and commission to WFA as a distribution expense fee for each note sold by WFA. The total underwriting discount and commission
and proceeds to Citigroup Global Markets Holdings Inc. shown above give effect to the actual underwriting discount and commission provided
for the sale of the notes.&nbsp;&nbsp;See &ldquo;Supplemental Plan of Distribution&rdquo; below and &ldquo;Use of Proceeds and Hedging&rdquo;
in the accompanying prospectus for further information regarding how we have hedged our obligations under the notes.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt; background-color: white">(3)
In respect of certain notes sold in this offering, CGMI may pay a fee of up to $2.00 per note to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the notes to other securities dealers.</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Citigroup Global Markets Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Wells Fargo
    Securities</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; width: 100%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Terms
    of the Notes</B></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Underlying:</B></FONT></TD>
    <TD STYLE="width: 80%; padding-left: 5.6pt"><FONT STYLE="font-size: 10pt">The Nasdaq-100 Index<SUP>&reg;</SUP></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt"><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Stated Principal Amount:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 per note. References in this pricing supplement to a &ldquo;note&rdquo; are to a note with a stated principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt"><FONT STYLE="font-size: 10pt">November 24, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt"><FONT STYLE="font-size: 10pt">November 28, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Calculation Day:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt; text-align: justify"><FONT STYLE="font-size: 10pt">November 26, 2029, subject to postponement if such date is not a trading day or certain market disruption events occur as described in the accompanying product supplement. </FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maturity Date:</B></FONT></TD>
    <TD STYLE="padding-left: 5.3pt"><FONT STYLE="font-size: 10pt">November 29, 2029, subject to postponement as described in the accompanying product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maturity Payment Amount:</B></FONT></TD>
    <TD STYLE="text-align: justify"><P STYLE="margin-left: 0.05in; margin-top: 0pt; margin-bottom: 0pt">For each $1,000 stated principal amount note you hold at maturity: &nbsp;</P>
                                    <P STYLE="margin-left: 0.05in; margin-top: 0pt; margin-bottom: 0pt">&bull;&nbsp;&nbsp; &nbsp;&nbsp;If
                                    the ending value is <B>greater than</B> the starting value: &nbsp;</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">$1,000 <I>plus</I> the lesser
                                    of: &nbsp;</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">(i) $1,000 &times; underlying return &times; participation rate; and</P>
                                    <P STYLE="margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt">(ii) the maximum return &nbsp;</P>
                                    <P STYLE="margin-left: 0.05in; margin-top: 0pt; margin-bottom: 0pt">&bull;&nbsp;&nbsp; &nbsp;&nbsp;If
                                    the ending value is <B>less than or equal to</B> the starting value:&nbsp;&nbsp;$1,000 &nbsp;</P>
                                    <P STYLE="margin-left: 0.05in; margin-top: 0pt; margin-bottom: 0pt"><B>If the ending value is less than or equal to the starting
                                    value, you will be repaid the stated principal amount of the notes at maturity but will not receive
                                    any positive return on your investment.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Participation Rate:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt"><FONT STYLE="font-size: 10pt">100% </FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Maximum Return:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">21.00% of the stated principal amount ($210 per note). Because of the maximum return, the maturity payment amount will not exceed $1,210 per note.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Starting Value:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt"><FONT STYLE="font-size: 10pt">24,873.85, the closing value of the underlying on the pricing date</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Ending Value:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the calculation day</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Underlying Return:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt; text-align: justify"><FONT STYLE="font-size: 10pt">(ending value &ndash; starting value) / starting value</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding-left: 6.6pt"><FONT STYLE="font-size: 10pt">CGMI</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: white 1pt solid; background-color: #E0E3E2; padding-left: 5.05pt"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding-left: 0.1in; text-align: justify"><FONT STYLE="font-size: 10pt">17331BUC1 / US17331BUC17</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Additional
    Information</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of the notes are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product
supplement, underlying supplement, prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing
supplement.&nbsp;&nbsp;For example, the accompanying product supplement contains important information about how the closing value of
the underlying will be determined and other specified events with respect to the underlying.&nbsp;&nbsp;The accompanying underlying supplement
contains information about the underlying that is not repeated in this pricing supplement.&nbsp;&nbsp;It is important that you read the
accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with this pricing supplement in
connection with your investment in the notes.&nbsp;&nbsp;Certain terms used but not defined in this pricing supplement are defined in
the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we refer to &ldquo;we,&rdquo; &ldquo;us&rdquo;
and &ldquo;our&rdquo; in this pricing supplement, we refer only to Citigroup Global Markets Holdings Inc. and not to any of its affiliates,
including Citigroup Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access the product supplement, underlying
supplement and prospectus supplement and prospectus on the SEC website www.sec.gov as follows (or if such address has changed, by reviewing
our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Product Supplement No. EA-09-02 dated March 23, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323004585/dp190174_424b2-wf0902.htm" STYLE="color: Blue; text-decoration: underline">https://www.sec.gov/Archives/edgar/data/200245/000095010323004585/dp190174_424b2-wf0902.htm</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Underlying Supplement No. 11 dated March 7, 2023:<FONT STYLE="background-color: yellow"><BR>
</FONT></FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Prospectus Supplement and Prospectus, each dated March 7, 2023:<FONT STYLE="background-color: yellow"><BR>
</FONT></FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-size: 10pt">https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Investor
    Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The notes are not appropriate for all investors.
The notes may be an appropriate investment for investors who: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek exposure to any upside performance of the underlying without exposure to any decline in the underlying,
by:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">participating at the specified participation rate in the percentage increase, if any, from the starting
value to the ending value, subject to the maximum return; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">providing for the repayment of the stated principal amount at maturity regardless of the performance of
the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">understand that if the ending value is less than or equal to the starting value, they will not receive
any positive return on their investment in the notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to forgo interest payments on the notes and dividends on securities included in the underlying;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are willing to hold the notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The notes may not be an appropriate investment
for investors who: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek a liquid investment or are unable or unwilling to hold the notes to maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek certainty of receiving a positive return on their investment;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek uncapped exposure to the upside performance of the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek current income;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to purchase notes with the estimated value set forth on the cover page;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the risk of exposure to the underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">seek exposure to the underlying but are unwilling to accept the risk/return trade-offs inherent in the
maturity payment amount for the notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">are unwilling to accept the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 17.95pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">prefer the lower risk of fixed income investments with comparable maturities issued by companies with
comparable credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the notes are an appropriate investment for you will depend on your individual circumstances, and you should
reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered the
appropriateness of an investment in the notes in light of your particular circumstances. You should also review carefully the &ldquo;Summary
Risk Factors&rdquo; herein and the &ldquo;Risk Factors&rdquo; in the accompanying product supplement for risks related to an investment
in the notes. For more information about the underlying, please see the information provided below. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Determining
    Maturity Payment Amount</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On
the maturity date, you will receive a cash payment per note (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Summary
    Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the notes is significantly riskier
than an investment in conventional debt securities.&nbsp;&nbsp;The notes are subject to all of the risks associated with an investment
in our conventional debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations
under the notes, and are also subject to risks associated with the underlying.&nbsp;&nbsp;Accordingly, the notes are appropriate only
for investors who are capable of understanding the complexities and risks of the notes.&nbsp;&nbsp;You should consult your own financial,
tax and legal advisors as to the risks of an investment in the notes and the appropriateness of the notes in light of your particular
circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of certain key risk
factors for investors in the notes.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating
to an investment in the notes contained in the section &ldquo;Risk Factors&rdquo; beginning on page PS-5 in the accompanying product supplement.&nbsp;&nbsp;You
should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated by reference
in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports
on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>You May Not Receive Any Positive
Return On Your Investment In The Notes.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">You will receive a positive
return on your investment in the notes only if the ending value is greater than the starting value. If the ending value is equal to or
less than the starting value, you will receive only the stated principal amount for each note you hold at maturity. As the notes do not
pay any interest, even if the ending value is greater than the starting value, there is no assurance that your total return at maturity
on the notes will be as great as could have been achieved on conventional debt securities of ours or of another issuer with a similar
credit rating of comparable maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>The Notes Do Not Pay Interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Unlike conventional debt securities,
the notes do not pay interest or any other amounts prior to maturity. You should not invest in the notes if you seek current income during
the term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Your Potential Return On
The Notes Is Limited.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Your potential total return
on the notes at maturity is limited to the maximum return. Your return on the notes will not exceed the maximum return, even if the underlying
appreciates by significantly more than the maximum return. If the underlying appreciates by more than the maximum return, the notes will
underperform an alternative investment providing 1-to-1 exposure to the performance of the underlying.&nbsp;&nbsp;When lost dividends
are taken into account, the notes may underperform an alternative investment providing 1-to-1 exposure to the performance of the underlying
and a pass-through of dividends even if the underlying appreciates by less than the maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>You Will Not Receive Dividends
Or Have Any Other Rights With Respect To The Securities Included In The Underlying.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">You will not receive any dividends
with respect to the securities included in the underlying.&nbsp;&nbsp;This lost dividend yield may be significant over the term of the
notes.&nbsp;&nbsp;The payment scenarios described in this pricing supplement do not show any effect of lost dividend yield over the term
of the notes.&nbsp;&nbsp;In addition, you will not have voting rights or any other rights with respect to the securities included in the
underlying.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Your Maturity Payment Amount
Depends On The Value Of The Underlying On A Single Day.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Because your maturity payment
amount depends on the value of the underlying solely on the calculation day, you are subject to the risk that the value of the underlying
on that day may be lower, and possibly significantly lower, than on one or more other dates during the term of the notes. If you had invested
in another instrument linked to the underlying that you could sell for full value at a time selected by you, or if the maturity payment
amount were based on an average of values of the underlying, you might have achieved better returns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Although The Notes Provide
For The Repayment Of The Stated Principal Amount At Maturity, You May Nevertheless Suffer A Loss On Your Investment In Real Value Terms
If The Percentage Change From The Starting Value to the Ending Value Is Less Than Or Not Sufficiently Greater Than Zero. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This is because inflation may
cause the real value of the stated principal amount to be less at maturity than it is at the time you invest, and because an investment
in the notes represents a forgone opportunity to invest in an alternative asset that does generate a positive real return. This potential
loss in real value terms is significant given the term of the notes. You should carefully consider whether an</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">investment that may not provide
for any positive return on your investment, or may provide a return that is lower than the return on alternative investments, is appropriate
for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>The Notes Are Subject To
The Credit Risk Of Citigroup Global Markets Holdings Inc. And Citigroup Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">If we default on our obligations
under the notes and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you under the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Notes Will Not Be Listed On Any Securities
Exchange And You May Not Be Able To Sell Them Prior To Maturity. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes will not be listed on any securities
exchange. Therefore, there may be little or no secondary market for the notes. We have been advised that Wells Fargo currently intends
to make a secondary market in relation to the notes. However, Wells Fargo may suspend or terminate making a market without notice, at
any time and for any reason. If Wells Fargo suspends or terminates making a market, there may be no secondary market at all for the notes
because it is likely that Wells Fargo will be the only broker-dealer that is willing to buy your notes prior to maturity. Accordingly,
an investor must be prepared to hold the notes until maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Sale Of The Notes Prior To Maturity May Result
In A Loss Of Principal.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will be entitled to receive at least the full
stated principal amount of your notes, subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc., only if
you hold the notes to maturity. The value of the notes may fluctuate during the term of the notes, and if you are able to sell your notes
prior to maturity, you may receive less than the full stated principal amount of your notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes On The Pricing
Date, Based On CGMI&rsquo;s Proprietary Pricing Models And Our Internal Funding Rate, Is Less Than The Public Offering Price. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference is attributable to certain costs
associated with selling, structuring and hedging the notes that are included in the public offering price. These costs include (i) any
selling concessions or other fees paid in connection with the offering of the notes, (ii) hedging and other costs incurred by us and our
affiliates in connection with the offering of the notes and (iii) the expected profit (which may be more or less than actual profit) to
CGMI or other of our affiliates and/or Wells Fargo or its affiliates in connection with hedging our obligations under the notes. These
costs adversely affect the economic terms of the notes because, if they were lower, the economic terms of the notes would be more favorable
to you. The economic terms of the notes are also likely to be adversely affected by the use of our internal funding rate, rather than
our secondary market rate, to price the notes. See &ldquo;The Estimated Value Of The Notes Would Be Lower If It Were Calculated Based
On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Was Determined
For Us By Our Affiliate Using Proprietary Pricing Models. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CGMI derived the estimated value disclosed on
the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have made discretionary judgments about
the inputs to its models, such as the volatility of the underlying, the dividend yields on the securities included in the underlying and
interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an underwriter in this offering,
CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to be wrong and therefore not an
accurate reflection of the value of the notes. Moreover, the estimated value of the notes set forth on the cover page of this pricing
supplement may differ from the value that we or our affiliates may determine for the notes for other purposes, including for accounting
purposes. You should not invest in the notes because of the estimated value of the notes. Instead, you should be willing to hold the notes
to maturity irrespective of the initial estimated value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Would Be Lower
If It Were Calculated Based On Wells Fargo&rsquo;s Determination Of The Secondary Market Rate With Respect To Us. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated value of the notes included in this
pricing supplement is calculated based on our internal funding rate, which is the rate at which we are willing to borrow funds through
the issuance of the notes. We expect that our internal funding rate is generally lower than Wells Fargo&rsquo;s determination of the secondary
market rate with respect to us, which is the rate that we expect Wells Fargo will use in determining the value of the notes for purposes
of any purchases of the notes from you in the secondary market. If the estimated value included in this pricing supplement were based
on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, rather than our internal funding rate, it would
likely be lower. We determine our internal funding rate based on factors such as the costs associated with the notes, which are generally
higher than the costs associated with conventional debt securities, and our liquidity needs and preferences. Our internal funding rate
is not an interest rate that is payable on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because there is not an active market for traded
instruments referencing our outstanding debt obligations, Wells Fargo may determine the secondary market rate with respect to us for purposes
of any purchase of the notes from you in the secondary market based on the market price of traded instruments referencing the debt obligations
of Citigroup Inc., our parent company and the guarantor of all payments due on the notes, but subject to adjustments that Wells Fargo
may deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Estimated Value Of The Notes Is Not An
Indication Of The Price, If Any, At Which Any Person May Be Willing To Buy The Notes From You In The Secondary Market. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such secondary market price will fluctuate
over the term of the notes based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value
included in this pricing supplement, we expect that any value of the notes determined for purposes of a secondary market transaction will
be based on Wells Fargo&rsquo;s determination of the secondary market rate with respect to us, which will likely result in a lower value
for the notes than if our internal funding rate were used. In addition, we expect that any secondary market price for the notes will be
reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the notes to be purchased in the secondary
market transaction, and may be reduced by the expected cost of unwinding related hedging transactions. As a result, it is likely that
any secondary market price for the notes will be less than the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Value Of The Notes Prior To Maturity Will
Fluctuate Based On Many Unpredictable Factors. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of your notes prior to maturity will
fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying, the dividend yields on
the securities included in the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s
creditworthiness, as reflected in our secondary market rate, among other factors described under <FONT STYLE="background-color: white">&ldquo;Ris</FONT>k
Factors&mdash;General Risk Factors Relating To All Notes&mdash; The Value Of Your Notes Prior To Maturity Will Fluctuate Based On Many
Unpredictable Factors&rdquo; in the accompanying product supplement.&nbsp;&nbsp;Changes in the value of the underlying may not result
in a comparable change in the value of your notes. You should understand that the value of your notes at any time prior to maturity may
be significantly less than the public offering price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We Have Been Advised That, Immediately Following
Issuance, Any Secondary Market Bid Price Provided By Wells Fargo, And The Value That Will Be Indicated On Any Brokerage Account Statements
Prepared By Wells Fargo Or Its Affiliates, Will Reflect A Temporary Upward Adjustment. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of this temporary upward adjustment
will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Offering Of The Notes Is Not A Recommendation
Of The Underlying. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fact that we are offering the notes does not
mean that we or Wells Fargo or its affiliates believe that investing in an instrument linked to the underlying is likely to achieve favorable
returns. In fact, as we and Wells Fargo and its affiliates are each part of respective global financial institutions, our affiliates and
affiliates of Wells Fargo may have positions (including short positions) in the underlying or in instruments related to the underlying,
and may publish research or express opinions, that in each case are inconsistent with an investment linked to the underlying. These and
other activities of our affiliates or of Wells Fargo or its affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Closing Value Of The Underlying May Be
Adversely Affected By Our Or Our Affiliates&rsquo;, Or By Wells Fargo And Its Affiliates&rsquo;, Hedging And Other Trading Activities.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have hedged our obligations under the notes
through CGMI or other of our affiliates and/or Wells Fargo or its affiliates, who have taken positions in the underlying or in financial
instruments related to the underlying and may adjust such positions during the term of the notes. Our affiliates and Wells Fargo and its
affiliates may also take positions in the underlying or in financial instruments related to the underlying on a regular basis (taking
long or short positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf
of customers. These activities could affect the closing value of the underlying in a way that negatively affects the value of and your
return on the notes. They could also result in substantial returns for us or our affiliates or Wells Fargo and its affiliates while the
value of the notes declines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We And Our Affiliates And Wells Fargo And Its
Affiliates May Have Economic Interests That Are Adverse To Yours As A Result Of Our And Their Respective Business Activities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our affiliates and Wells Fargo and its affiliates
engage in business activities with a wide range of companies.&nbsp;&nbsp;These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services.&nbsp;&nbsp;These activities could involve or affect the
underlying in a way that negatively affects the value of and your return on the notes. They could also result in substantial returns for
us or our affiliates or Wells Fargo or its affiliates while the value of the notes declines.&nbsp;&nbsp;In addition, in the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">course of this business, we or our affiliates
or Wells Fargo or its affiliates may acquire non-public information, which will not be disclosed to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Calculation Agent, Which Is An Affiliate
Of Ours, Will Make Important Determinations With Respect To The Notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If certain events occur during the term of the
notes, such as market disruption events and other events with respect to the underlying, CGMI, as calculation agent, will be required
to make discretionary judgments that could significantly affect your return on the notes.&nbsp;&nbsp;In making these judgments, the calculation
agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder of the notes.&nbsp;&nbsp;<FONT STYLE="background-color: white">See
&ldquo;Risk Facto</FONT>rs&mdash;General Risk Factors Relating To All Notes&mdash;The Calculation Agent, Which Is An Affiliate Of Ours,
Will Make Important Determinations With Respect To The Notes&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Changes That Affect The Underlying May Affect
The Value Of Your Notes. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sponsor of the underlying may at any time
make methodological changes or other changes in the manner in which it operates that could affect the value of the underlying.&nbsp;&nbsp;We
are not affiliated with the underlying sponsor and, accordingly, we have no control over any changes the sponsor may make.&nbsp;&nbsp;Such
changes could adversely affect the performance of the underlying and the value of and your return on the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Stated Maturity Date May Be Postponed If
The Calculation Day Is Postponed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The calculation day will be postponed for non-trading
days and certain market disruption events. If such a postponement occurs, the maturity date will be postponed. For more information regarding
adjustments to the calculation days and payment dates and the circumstances that may result in a market disruption event, see the relevant
sections of the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You Will Be Required To Recognize Taxable Income
On The Notes Prior To Maturity</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a U.S. holder of a note, you will be
required to recognize taxable interest income in each year that you hold the note, even though you will not receive any payment in respect
of the note prior to maturity (or earlier sale, exchange or retirement). In addition, any gain you recognize will be treated as ordinary
interest income rather than capital gain. You should review the section of this pricing supplement entitled &ldquo;United States Federal
Tax Considerations.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Hypothetical
    Examples and Returns</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate how to determine the maturity payment amount on the notes, assuming the various hypothetical ending values indicated
below.&nbsp;&nbsp;The examples are solely for illustrative purposes, do not show all possible outcomes and are not a prediction of what
the actual maturity payment amount on the notes will be.&nbsp;&nbsp;The actual maturity payment amount will depend on the actual ending
value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The examples below are based on a hypothetical
starting value of 100, rather than the actual starting value.&nbsp;&nbsp;For the actual starting value, see &ldquo;Terms of the Notes&rdquo;
above.&nbsp;&nbsp;We have used this hypothetical value, rather than the actual value, to simplify the calculations and aid understanding
of how the notes work.&nbsp;&nbsp;However, you should understand that the actual maturity payment amount on the notes will be calculated
based on the actual starting value, and not the hypothetical value indicated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.gif" ALT="" STYLE="width: 685px; height: 432px"></P>

<TABLE CELLPADDING="2" CELLSPACING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Wingdings; color: #4A7EBB">n</FONT>&nbsp;The
Notes&nbsp;&nbsp;&nbsp;&#9;<FONT STYLE="font-family: Wingdings">n</FONT>&nbsp;The Underlying</P></TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: #688FCF 1pt solid; width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hypothetical</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ending value</B></P></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical underlying return</B></FONT></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical maturity payment amount per&nbsp;note</B></FONT></TD>
    <TD STYLE="border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Hypothetical total pre-tax rate&nbsp;of&nbsp;return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">200.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">175.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">150.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">140.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">130.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">121.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">120.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,200.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">110.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">10.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">105.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">5.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">90.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">80.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-20.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">70.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-30.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">60.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">25.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1&mdash;Upside Scenario A.</B> The
hypothetical ending value is 105 (a 5% increase from the starting value), which is <B>greater than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000 <I>plus </I>the lesser of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) $1,000 &times; underlying return &times; participation rate and
(ii) the maximum return</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) ($1,000 &times; 5% &times; 100%) and
(ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) $50 and (ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,050</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the underlying appreciated from the starting
value to the hypothetical ending value, you would receive a total return at maturity equal to the upside performance of the underlying
<I>multiplied by</I> the participation rate, which in this case is less than the maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2&mdash;Upside Scenario B.</B> The
hypothetical ending value is 140 (a 40% increase from the starting value), which is <B>greater than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000 <I>plus </I>the lesser of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) $1,000 &times; underlying return &times; participation rate and
(ii) the maximum return</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) ($1,000 &times; 40% &times; 100%) and
(ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,000 + the lesser of: (i) $400 and (ii) $210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">= $1,210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the underlying appreciated from the starting
value to the hypothetical ending value and the upside performance of the underlying <I>multiplied by</I> the participation rate exceeds
the maximum return, your total return at maturity would be limited to the maximum return in this case. In this scenario, an investment
in the notes would underperform a hypothetical alternative investment providing 1-to-1 exposure to the appreciation of the underlying
without a maximum return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3&mdash;Par Scenario.</B> The hypothetical
ending value is 90 (a 10% decrease from the starting value), which is <B>less than</B> the starting value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity payment amount per note = $1,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending value is less
than the starting value, you would be repaid the stated principal amount of your notes at maturity but would not receive any positive
return on your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Information
    About the Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified
market capitalization-weighted index of stocks of the 100 largest non-financial companies listed on the Nasdaq Stock Market. All stocks
included in the Nasdaq-100 Index<SUP>&reg;</SUP> are traded on a major U.S. exchange. The Nasdaq-100 Index<SUP>&reg;</SUP> was developed
by the Nasdaq Stock Market, Inc. and is calculated, maintained and published by Nasdaq, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please refer to the section &ldquo;Equity Index
Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have derived all information regarding the
Nasdaq-100 Index<SUP>&reg;</SUP> from publicly available information and have not independently verified any information regarding the
Nasdaq-100 Index<SUP>&reg;</SUP>. This pricing supplement relates only to the notes and not to the Nasdaq-100 Index<SUP>&reg;</SUP>. We
make no representation as to the performance of the Nasdaq-100 Index<SUP>&reg;</SUP> over the term of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes represent obligations of Citigroup Global
Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Nasdaq-100 Index<SUP>&reg;</SUP> is not involved in any
way in this offering and has no obligation relating to the notes or to holders of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historical Information </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The closing value of the Nasdaq-100 Index<SUP>&reg;</SUP> on November
24, 2025 was 24,873.85.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below shows the closing value of the
Nasdaq-100 Index<SUP>&reg;</SUP> for each day such value was available from January 2, 2020 to November 24, 2025.&nbsp;&nbsp;We obtained
the closing values from Bloomberg L.P., without independent verification.&nbsp;&nbsp;You should not take historical closing values as
an indication of future performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_003.gif" ALT="" STYLE="height: 320px; width: 599px"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>United
    States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of our counsel, Davis Polk &amp;
Wardwell LLP, which is based on current market conditions, the notes should be treated as &ldquo;contingent payment debt instruments&rdquo;
for U.S. federal income tax purposes, as described in the section of the accompanying product supplement called &ldquo;United States Federal
Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Contingent Payment Debt Instruments,&rdquo; and the remaining
discussion is based on this treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a U.S. Holder (as defined in the accompanying
product supplement), you will be required to recognize interest income during the term of the notes at the &ldquo;comparable yield,&rdquo;
which generally is the yield at which we could issue a fixed-rate debt instrument with terms similar to those of the notes, including
the level of subordination, term, timing of payments and general market conditions, but excluding any adjustments for the riskiness of
the contingencies or the liquidity of the notes.&nbsp;&nbsp;We are required to construct a &ldquo;projected payment schedule&rdquo; in
respect of the notes representing a payment the amount and timing of which would produce a yield to maturity on the notes equal to the
comparable yield.&nbsp;&nbsp;Assuming you hold the notes until their maturity, the amount of interest you include in income based on the
comparable yield in the taxable year in which the notes mature will be adjusted upward or downward to reflect the difference, if any,
between the actual and projected payment on the notes at maturity as determined under the projected payment schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the sale, exchange or retirement of the notes
prior to maturity, you generally will recognize gain or loss equal to the difference between the proceeds received and your adjusted tax
basis in the notes.&nbsp;&nbsp;Your adjusted tax basis will equal your purchase price for the notes, increased by interest previously
included in income on the notes.&nbsp;&nbsp;Any gain generally will be treated as ordinary income, and any loss generally will be treated
as ordinary loss to the extent of prior interest inclusions on the note and as capital loss thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have determined that the comparable yield for
a note is a rate of 4.147%, compounded semi-annually, and that the projected payment schedule with respect to a note consists of a single
payment of $1,178.637 at maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>ACCRUAL PERIOD</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>OID DEEMED TO ACCRUE DURING ACCRUAL PERIOD (PER NOTE)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>TOTAL OID DEEMED TO HAVE ACCRUED FROM ISSUE DATE (PER NOTE) AS OF END OF ACCRUAL PERIOD</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">Issue Date</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 6%; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2025</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt">$3.686</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt">$3.686</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$20.811</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$24.498</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2026</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$21.243</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$45.741</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$21.683</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$67.424</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2027</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$22.133</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$89.557</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$22.592</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$112.149</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2028</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$23.060</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$135.209</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">January 1, 2029</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">June 30, 2029</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$23.539</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$158.748</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">July 1, 2029</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">Maturity Date</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$19.889</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$178.637</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the comparable yield nor the projected
payment schedule constitutes a representation by us regarding the actual amount that we will pay on the notes.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-U.S. Holders.</B> Subject to the discussions
below regarding Section 871(m) and in &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo;
and &ldquo;&mdash;FATCA&rdquo; in the accompanying product&nbsp;&nbsp;supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the notes, under current law you generally will not be subject to U.S. federal withholding or income tax in respect
of any payment on or any amount received on the sale, exchange or retirement of the notes, provided that (i) income in respect of the
notes is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply with the applicable
certification requirements.&nbsp;&nbsp;See &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo;
in the accompanying product supplement for a more detailed discussion of the rules applicable to Non-U.S. Holders of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed under &ldquo;United States Federal
Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&mdash;Dividend Equivalents Under Section 871(m) of the Code&rdquo; in the
accompanying product supplement, Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;Underlying Securities&rdquo;)&nbsp;&nbsp;or indices
that include Underlying Securities.&nbsp;&nbsp;Section 871(m) generally applies to instruments that substantially replicate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the economic performance of one or more Underlying
Securities, as determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However, the regulations, as modified
by an Internal Revenue Service (&ldquo;IRS&rdquo;) notice, exempt financial instruments issued prior to January 1, 2027 that do not have
a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based on the terms of the notes and representations provided by us, our counsel is of the opinion
that the notes should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with
respect to any Underlying Security and, therefore, should not be subject to withholding tax under Section 871(m).&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A determination that the notes are not subject
to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section 871(m) is complex
and its application may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should consult your
tax adviser regarding the potential application of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If withholding tax applies to the notes, we will
not be required to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should read the section entitled &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination
with that section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences
of owning and disposing of the notes.&nbsp;&nbsp; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should also consult your tax adviser regarding
all aspects of the U.S. federal tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #0070C0; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Supplemental
    Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Amended and Restated
Global Selling Agency Agreement, dated April 7, 2017, CGMI, acting as principal, will purchase the notes from Citigroup Global Markets
Holdings Inc. CGMI, as the lead agent for the offering, has agreed to sell the notes to Wells Fargo, as agent.&nbsp;&nbsp;Wells Fargo
will receive an underwriting discount and commission of 3.83% ($38.30) for each note it sells.&nbsp;&nbsp;Wells Fargo may pay selected
dealers, which may include WFA, a fixed selling commission of 2.75% ($27.50) for each note they sell. In addition to the selling commission
allowed to WFA, Wells Fargo may pay $0.75 per note of the underwriting discount and commission to WFA as a distribution expense fee for
each note sold by WFA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In addition,
in respect of certain notes sold in this offering, CGMI may pay a fee of up to $2.00 per note to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the notes to other securities dealers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Valuation
    of the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CGMI calculated the estimated value of the notes
set forth on the cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated
an estimated value for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout
on the notes, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the notes (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component using
a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The Value Of The Notes Prior To Maturity Will Fluctuate
Based On Many Unpredictable Factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have been advised that, for a period of approximately
four months following issuance of the notes, the price, if any, at which Wells Fargo would be willing to buy the notes from investors,
and the value that will be indicated for the notes on any brokerage account statements prepared by Wells Fargo or its affiliates, will
reflect a temporary upward adjustment from the price or value that would otherwise be determined.&nbsp;&nbsp;This temporary upward adjustment
represents a portion of the costs associated with selling, structuring and hedging the notes that are included in the public offering
price of the notes.&nbsp;&nbsp;The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the four-month
temporary adjustment period.&nbsp;&nbsp;However, Wells Fargo is not obligated to buy the notes from investors at any time.&nbsp;&nbsp;See
&ldquo;Summary Risk Factors&mdash;The Notes Will Not Be Listed On Any Securities Exchange And You May Not Be Able To Sell Them Prior To
Maturity.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #688FCF">
    <TD STYLE="padding: 4pt; text-align: center; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: white"><B>Validity
    of the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special products counsel to Citigroup Global Markets Holdings Inc., when the notes offered by this pricing supplement have been executed
and issued by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against
payment therefor, such notes and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets
Holdings Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy,
insolvency and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general
applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel
expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions
expressed above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York,
except that such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In giving this opinion, Davis Polk &amp; Wardwell
LLP has assumed the legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup
Global Markets Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In
addition, this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024,
which has been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has
been duly authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the
terms of the notes nor the issuance and delivery of the notes and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the notes and the related guarantee respectively, will result in a violation of any
provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or
any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Alexia Breuvart, Secretary and
General Counsel of Citigroup Global Markets Holdings Inc., (i) the terms of the notes offered by this pricing supplement have been duly
established under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings
Inc. has duly authorized the issuance and sale of such notes and such</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR><TD STYLE="vertical-align: top; width: 82%"> <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.6pt 0pt 0; color: #BB0826"><B>Market Linked Notes&mdash; Upside Participation to a Cap and Principal Return at Maturity</B></P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Notes Linked to the Nasdaq-100 Index<SUP>&reg;</SUP> due November 29, 2029 </B></P></TD><TD STYLE="white-space: nowrap; width: 18%; font-size: 12pt; text-align: right"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B><IMG SRC="image_001.jpg" ALT=""></B></FONT></TD></TR></TABLE><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">authorization has not been modified or rescinded;
(ii) Citigroup Global Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the
indenture has been duly authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery
of such indenture and of the notes offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by
Citigroup Global Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate
of incorporation or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited
to the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alexia Breuvart, or other internal attorneys with
whom she has consulted, has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction,
of such corporate records of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis
for the opinions expressed above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the
genuineness of all signatures (other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all documents
submitted to her or such persons as originals, the conformity to original documents of all documents submitted to her or such persons
as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Karen Wang, Senior Vice President
&ndash; Corporate Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of
Citigroup Inc. has duly authorized the guarantee of such notes by Citigroup Inc. and such authorization has not been modified or rescinded;
(ii) Citigroup Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup
Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or
other constitutive documents.&nbsp;&nbsp;This opinion is given as of the date of this pricing supplement and is limited to the General
Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Karen Wang, or other internal attorneys with whom
she has consulted, has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such
corporate records of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above.
In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other
than those of officers of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity
to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the
originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&copy; 2025 Citigroup Global Markets Inc. All
rights reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered
throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp237978_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-26</xbrli:startDate>
          <xbrli:endDate>2025-11-26</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-26</xbrli:startDate>
          <xbrli:endDate>2025-11-26</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-26</xbrli:startDate>
          <xbrli:endDate>2025-11-26</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">530</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">530,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">73.19</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">530,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">73.19</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">73.19</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">530,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !! %X# 2(  A$! Q$!_\0
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MC/<$5TU+JG'EV$MS/LOA[H>G^(UU>UM_+=%^2$?ZM'_O =C7F]I_R7%_^O\
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KLDGID^M:U%)S;7* 4445(!1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #= K<# 2(  A$! Q$!_\0
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M'_"1>*/^@!H__@XE_P#D:IZ*/:R"Q!_PD7BC_H :/_X.)?\ Y&H_X2+Q1_T
M-'_\'$O_ ,C5/11[606(/^$B\4?] #1__!Q+_P#(U'_"1>*/^@!H_P#X.)?_
M )&J>BCVL@L0?\)%XH_Z &C_ /@XE_\ D:C_ (2+Q1_T -'_ /!Q+_\ (U3T
M4>UD%B#_ (2+Q1_T -'_ /!Q+_\ (U'_  D7BC_H :/_ .#B7_Y&J>BCVL@L
M0?\ "1>*/^@!H_\ X.)?_D:C_A(O%'_0 T?_ ,'$O_R-4]%'M9!8@_X2+Q1_
MT -'_P#!Q+_\C4?\)%XH_P"@!H__ (.)?_D:IZ*/:R"Q!_PD7BC_ * &C_\
M@XE_^1J/^$B\4?\ 0 T?_P '$O\ \C5/11[606(/^$B\4?\ 0 T?_P '$O\
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M\4?] #1__!Q+_P#(U3T4>UD%B#_A(O%'_0 T?_P<2_\ R-1_PD7BC_H :/\
M^#B7_P"1JGHH]K(+$'_"1>*/^@!H_P#X.)?_ )&H_P"$B\4?] #1_P#P<2__
M "-4]%'M9!8@_P"$B\4?] #1_P#P<2__ "-1_P )%XH_Z &C_P#@XE_^1JGH
MH]K(+$'_  D7BC_H :/_ .#B7_Y&H_X2+Q1_T -'_P#!Q+_\C5/11[606(/^
M$B\4?] #1_\ P<2__(U'_"1>*/\ H :/_P"#B7_Y&J>BCVL@L0?\)%XH_P"@
M!H__ (.)?_D:C_A(O%'_ $ -'_\ !Q+_ /(U3T4>UD%B#_A(O%'_ $ -'_\
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M&W QQ@\G/%^I **** "BBB@ HHHH I:=^Y^(=OMR/M6E3^9SU\J6+;_Z.?\
M.BEL_P#DH>F?]@J]_P#1MI1773^%$LSOB%_R-.@?]>5[_P"AVU8-;WQ"_P"1
MIT#_ *\KW_T.VK!KKI_"<M7XB>*\NH"IBN9H]JE5V2$8!.2![9YJ+S)!+YH=
MO,W;M^><^N?6FUT_AZ4[;&.WG2/;/(;F,R %QM&TX[CK]#S[U;=B4KNQS[WM
MU(Q9[F9F*E"6D).T]1]#36NKA[=;=IY3"IR(RYVC\.E=#!?PJVEQ/<#8ELV
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MY1#!;P;=\KD$X&XA1A0Q)) P#6=+XNLQ8VEQ;6EY=RW*R.+:!4\U%CXD+!F
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M2AZ9_P!@J]_]&VE%=5/X4)F=\0O^1IT#_KRO?_0[:L&M[XA?\C3H'_7E>_\
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M#D]^YJ[16)N4K71M+L;VXO;/3;.WNKDYGGA@5'E.<Y9@,MSSS5VBB@ HHHH
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M_?\ L_\ Y(KN**/91"YP_P!LUO\ Z$_6/^_]G_\ )%'VS6_^A/UC_O\ V?\
M\D5W%%'LHA<X?[9K?_0GZQ_W_L__ )(H^V:W_P!"?K'_ '_L_P#Y(KN**/91
M"YP_VS6_^A/UC_O_ &?_ ,D4?;-;_P"A/UC_ +_V?_R17<44>RB%SA_MFM_]
M"?K'_?\ L_\ Y(H^V:W_ -"?K'_?^S_^2*[BBCV40N</]LUO_H3]8_[_ -G_
M /)%'VS6_P#H3]8_[_V?_P D5W%%'LHA<X?[9K?_ $)^L?\ ?^S_ /DBC[9K
M?_0GZQ_W_L__ )(KN**/91"YP_VS6_\ H3]8_P"_]G_\D4?;-;_Z$_6/^_\
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M3]8_[_V?_P D4?;-;_Z$_6/^_P#9_P#R17<44>RB%SA_MFM_]"?K'_?^S_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.gif
M1TE&.#=AK0*P 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M> $# '_[*C20(+!>A CL <AK@+V^_?L^%1#@('O@ PR4!>  ?0 0<  &!!I
MP8("21 ??A!&*&%+^H70'P"(*3:?0 10($%B #" @047"'3/@P))1\"*%T[H
MXHM;*6 >5 _L)X! "QSPCV(6$!@;!0<(9$ #!Y0(@ 0S*O9 !1-@0 ",4$99
ME0(A?/"49PI,P ![ 1P@V8X"K0<  @,HT(\!  1 0 45/ F >PFU*>6<="I5
MP'X??-?4! UX6,\$"S!P3S\-3!! /_PH!U]B"N@3@048_!. ! <*H:=!Z[A9
MYZ:<YK>9<$\=L ]_ #3 P*D,+"!CD _4TUF*!%C_T-B8]4A CT(3:-KIKKS.
MU  !Z"Q 50&@0D;!.AOUHVNOS#9[$@7HL-#B5@@T<.E%N3JK[;8A8< "!=3U
M%0&:W)9K;D6B2AM8MN>VZ^Y"#7Q;;%_*OFOOO0 \( $'! K&+KX ;_M O [,
M.MBX 2?<; 4L$) D8?\J+#&="EC @CR7U3OQQE%&4.6T$"_+\<CXJ6;M; B3
MK')]BW' P7BS1;SRS+/=R<$'_-BF,<T\6Q;!J/-B)G//1/\E'0OQA&M;RD4W
MW=<%'TQ7W]!.5TV7M_UBM[/57,<%G+KW4=WUV&<I$.\%UV+'--ELFQ4!"Q\$
M&:'8;=>]E;Z<N;BUW7QK__4V 4&'+7+?A$LEW3X@OKAVX8P_M0 (P45)=^.4
M$Q7 9@04(.7>E7<N5 "J<<"/YE).[OGI.%4(,HR+H^XZ3@< *^RFIK]N.TL!
M,,!"UG5R?OOO+&' @0,P<UH[\,B#-.GNS+:>_/,A41""!+/W>CSTV%/T@ 4<
M),ZL[]F'KWV\#.2L[?7BIX_0 BQD\+"SSJLOOT)O8VPN^O.GK]\'O&\+?OX
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MR2A  M0YE  LT(]1-N "$I F09K8S+IMKWN!F10("%#_#P-(@( &P64&74,
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M70IU&^ ,&M"O*[ #>]=C(P(:LB83AX<<O-JCH2<".W ,K:L!B[ #I0*44MH
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M @0$55%*5#<+&*HZ;5?":NZCNR#P7C*Q'25S[?(WJM5->]?-'-06L (0$(
M%&GM=1M)2"[-#KS_<Y/.?JN3'_1  #^>#.6"RVB<"U\-6W\3MU.!6S45@+@A
MT?')3T[:)L1]RSJNW?#T*$ ?8$9/4K_'6DBA,;U!$2A60A#N5:K#G9$L[U!T
MB]X1F8T !FA<)(5X4[,-%<. *< $ZDWRB;(0/0*WC;PMM8 #,-8M#Y#'(P7P
M@7!:U'Q!08T%*- IN$7 P;510)/ZP342<JKKDAFY7"X0@EW^8]0@0LD#D@0
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M4)I_&)W[Z@P.$($%V =["::H4#JV:( TPA!!D@X"D "(VA#-H!+JJ*Z;B3A
MJ*IZ28E.P[UZ 1$^TI2200[$:HHXNB/-L#%S42C- (%]B$"A\8J3N0]R @L"
MD <.:#P)H U4I( @P@!T$#-=DH]#O$&OT)<=^0#X,)N[ (">01!E!!#.VH[(
M,A6HJ(I5Q(#%2*I1*S'1**76.9$/N  $($( V*8*6,6YZA_WJ0T'4 IY6 X)
M60ZK&$"^J8!/ @1W&XK_:U3(DRB;[5$2]JD*">"HDU" >V" U8L[N:B'1P,
M/I(33 ( !) ?)4I)"C!"ED2>703&(>*VT; ST;  %HL*SB@LP",C#D ]!:N/
M'G( #/@'WA -D%&;ALF '<.;AN(B$=B'S,B6I, 8 &BNB0M!&V,Z#K$*Y*"
M-(K!"+"1S^"12$*B$V& _\D1W1JU-&HI0T2;A'J;,+0 !*@'!K"T"\@*!_(V
M&1H9!9@N.[0))L.L:2D<]V&QWD BE^#!U9@6!T 36D0)4;L,":!!KN%,5;(
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MZRHI2C%/5%0)"Z@-W>H1"A#.VF&!G7F;"\@ 2[T "7" IVJ #(C7:QF94&V
MA T,H)H1N,'#FRJ 7<D;Z+BIYF@*KMF5 0(2.2M8EMU;PWC9&2&]L%A5+F(
MY2 / YBBH>%.<W$GVX, T-@NC"L-!$"* V !).. ]TS/#LH2NXR)"-B'5QN?
M_6 Q_S%$(T(A@,I $D6- (53@)WUC865D9RZCY-X2[/9"IY#$O32/@^Y2L@0
MF8@$ 4S[CP!X&A8%% M@VL-H &85$3W+0#W)H59\@+DK'OY8H"G1"UD*#??)
MC/I)40  I00-CGOH(NPH@&@TK;^]BK(1#0*9KOQHFPKPPM7Y !: 8!8 2S!R
M5P5QSK29#%?;)M[:,=Z!H0PTBM\; &?J7!<Q"Q" 5&O*6!FQ.*M8#$KIB@S
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MY/%P&<N4(+-5(9X':)"49%25:'04NH__&\RT<*^:&?=W%S$85;*/*R21 UD
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MM6V%Q 4%!UC>3;#-5HP0&WIA3RQ &"8(8CC M_5(:&WAM%1;%C(B3YP85T2
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M+,"HE-@'05:53?_  G! !DSE9$SP1$2 6L'' 4Q/[-H$#R.@!=@'6=VN CB
M.OG'7M1O:+6/FI&M0I6'>G(9>#PBM$( !ZR. 2#1!_@9Z(POA.P+J1AMZX:(
MH5Y S"0J@DQQ=-W)%3L+@1I.1\BLIJ09PME%>4!D/7!(/9@L!^05#Q'HS:C+
MG3;$\0R.7LX&IK6;+2%D8;('(+QJB9%MHB 1E(V..(U%X9BO.BQ%;ASM?; $
M?*0<"Y#&/RP(I:B7JEGL0SQ/%"(%=5RM?TB4 L@#1Q'  $Q5D.YR '*$S":$
M 1 )<SG+^L[& O,9N2;Q7K@$*4%O01PF!#SB4MA$:4YNVGC1 7@1YP[_#@/
M$T60T1MM7\HMQ@E#) %D+*4&;5SJQ/AQ:@%4S($@%@RM;S_H0VH$[$ X(GR
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MEMBKZO+?)O9L":0%Y)FP>'64)@I,VP2]^D=-EB6BM0B>;HBN1@04186C+<
M8>N;M2$$4*?C1"GWS'7#JEM$R$-",V-J2-8Q8[/?%F<5@D=(5%)PQ+/6%+'[
M;'5D.4OU7L#K5/&Q1@"X\A@I1\33S@88*H[6_/ #Z$,\,H]L*%9LKF)03N5:
MJ;5I8(#JR,]+O"<"2,ALH0I, S$ ".]: XA1NM9_-/5#J-KI7$"& H 0CC5W
M!, ^0*M.C+:CZD1P0(6V-40&W 44D3< 0$ ]<!.'ZX3&--)V.^-BE.XT7T0
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MA D,%528L"##!P2C(2LX7D#! ^$0'ZQ[\,#O0 8?!'^PG+#?Z @L+"A8H*!
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<[KGIKMONN_'.6^^]^>[;[[\!#USPP0D_*B  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.gif
M1TE&.#=A5P)  7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M<"ISG.<L9S?!N4YR6K.=Z7PG.I_)SGE.,YZVG*$J<Y7_@R-Y)X5%1-(Y!(B
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M"PZ?))T,_NT_4L"N%/_QHGK_M.8H@<4D'@> >.9E VA_&F>  JB )J2 ?\:
M".B !+B 3'* %?B #">! MA_$/A_%]B ";B!(3B!(UB )=B!,?2!/I>"".B!
M)+AN(@B#*"B#)DB#%FB#*JB!-1B +[B",>B#&5B!$>B".SA>4P8EPY8D+(-@
M#FAL3Q98X]!^3#8 *(5_1;A82M=LA8 !G* CT]9MWH$/@6,I^F CE ,!!:
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M[>BQ(K=2;0Q3;-J_97D.!.HY*__LC&3C=B0M=JO+V$-Y AVX-2W+K18H8$"
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MYM[\PH*6Z+T6  G*D91/CQ<BR"((QHE'*P@0,L">?OP$( &M&FBY'  :2#2
M1PFR9^:7RPL@!_;NU>M>E'9#D#X7J2LJ*OJ"#BU,92\[F%\Q_U4*ZR7%AK73
M0*Q*V\^E+_6:L"WI"O8Z5FJKXTDGE]8-BR<M^=U:+P/?2W6OF[XFUL"2(B3[
M;K-[1;ONM=5NVS#%XHZ00:#M;JDFL!-_\3*:THS0Z,>Q#JQR+ENJ-ZMR;>5<
MMHY8E%K,M'>K/*PP6Z+LQK(\9'W,R;DNYXODY*1@ CF=H^!UC!DK0,^/AU^(
MYIX5Z#B !+X)H!]$&SBH 3_-4;YCZ9M7H +H T#TH'7"P9 L?=-=#3$DQ1G
M-_V ^@J^%PDL.E?@I*)WWR2'B@Y!F;ID<LJ2R ('4G3C% -9B".$89:^](.?
M*!T()O,31ZYT(\#RC<. + $'4WI$%O_[27!?!%K@ 0N3P. L<#H-Q,]((.A!
MK5 0@QZYX$DTZ)6-='!\+XQ)"-,WPGYYT(3NVQL.DP2_]F%$'/MR%:^@E)>2
M\ I45BN)!)-4O_*A9"E?60J^NE1#&2FHA63I3PDM"  +V X!"TC.!,KA' Q@
M@ )TV@_& E@4 B2/>,0C@/#$D8 $C"-ZZ@B /AJU/0BLIQ[5BYZ> ##(@T
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M!>AU8#2ZN$1?I2*UG.&:)]-[<D"!-QE"72V!S;4L0YJ/7%?LV>D.F,.KD/2
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M_]F@CC>S27B!EPT"%4'\J_^;11F1#! 9/!31"2,KAZ$8COU!(P30! I((<=
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MW3F'WNJJ<LT@8BW:K*L B!DRE/U78KW6L]6-AY7;:+4K;4-5AI@9!2" 1$F
M1GD'?Q"O]BHO^$JO!M"'>K (Z8$'/6F 2_(.]L@O&TNRRG4QR\7<S-5<'=O<
MSO5<$_/<T!7=T:W<"2/=T07=TU7=T!4RBI&9?FC=.$D."C 'SZ4 JDN.<Y"
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M!+@ZHXAJ?&,H3'V3WM'#@"S)V>R;H],)7OY=2SG50DJ(;X  XQ%#,M3",X0
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MD#BF7AM>J/NEW,*F \==G5QYYF6:.0@D".#Y,^C0HD>3)@V@ 00"!OIYAE#
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MAESP #BR>N.9)]N7[LF#,MPQR3)K'.6/ 9/L(Z9:DCQPK#;R?++&F,;Z+I-
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MB03 /PF(&9XA&J:A&JXA&[:A&[ZA<U@ "-J%?-3%L9C# ]3%?A!.YS68!
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M;0X1LLF-G]S181HB@/0#@WW!L4BG GTGQ'Q4:>[1H=K1:[ZH@0"  D2( 2@
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M@=+7*<62JH12B@:7*^DBM8;6E';DY%!)3$XKL(!*8#PF>U! -6+D@TX+@$C
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M< 9N;-:"U-.'* ! ) A @%Z#!@ "! !@$ *!  D:*!"8<)T# !?'B0,P#L"
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MR9)0[T8!:[I:%.!J%$<H@Y) B>$P)%3,Y$6EJY%@U(\,S,D6R9Y"-$6E;KK
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MA6"(;.IR4AX@L!F;K_6Z#!6QK<%PKEG1$:V0%CD['+40&K70L#%;$FV'%@L
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M=#=OM?"9Y4Z766,8?"&-Z]?*43DJ6!4-SJQ#,40M4&[LJ,@ !<G 2%F9. W
MU(8()":  C:,N<[WC]09?9754L[W0F(+G?^WKEP/KJ3#\&0?2YL,D%+TX**K
MR^*>]H&UV]/JXP%M@G?+'+P $,)@![R@N2NGB\H. *#[D,!$W*GBMQK)D&GJ
M[UR6Y7%*I$(JW4<.9L-.89D?X2.5Y/C6TTIN2DN*#*SG"ZI!*LH!U0'"
MX\3E*%?.0+DO""@80@#QRP0  P@"$%B0X#J- SE6%#>.(L6"X__6A<1HTN!
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M#$A5L2**U[0M$&L7Y2[>JXE*B!+N_ !I99XAC/OTM9[BY<  P@/6!A]0%:I
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M+TQ)JTO"QSO#J_M8HTMA_\M?M*O"JZN_ )S"D]5KJN@ 8? -J00(:M>X2],
M"K "_:,T:3(."2 .^.!I!B2G^!!E$41F"<!D748G:N9H^M 1:.QF:OQF;,Q!
M;KQ"_O  &)!H9% /I88>>S,5"S!^]@$ >CP5$R"I;=Q$<(P>_0#'FHD,P5*'
MO/,%260.DW9.#\#&AEQ"^@"C.2"LC6;)*(3&, H G<Q!H@<19 #_RJM&.6X$
MQZOL1)TLR@/QRFF,'I4,9VYLR[)<R+@<:;$LRUBJBM\ " 0@!C(3&VK2#PK
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M\0*,:R#.)0 %-%_N($DR1U$ !XLN1$B0)%.G),4AA3J0I%6K2 =.17HUJE0
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M?9M,E %$)1("[ T ^'C)/L:&$_2=CR;]0!  OE&.A]3C?!$!E5,^4Q"!H'$
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MK0F67$$)H+')F529FJ1)F8R:=MD'DAP687$6::D:IZD:8-G)C[R9HLE)FTF
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M 7#90 /U+*8Y!(DEH'D" 1"@@.;Z*%:/YQ4$$+H"H\O;97R%FN:?XD9G*!@
M$WPAVSGB]%-!.7@NU)?)/"X,:=PTX8UW\;/67B;7SMG)7H@E.B60H)A&]%))
M*[IDTHEWV3JLP\4_+Y1[=-(8K=EGH2C5UA<-31;]*1ITOZ,,(_IK].4.+F_6
MTQ/B]I<AK+@%0RKS$(K&AIP[I0Q%$.S_7K":D[>-U"5Y7OF)K'J#MNLY#V'2
M,XW;?C*1ES2$=B *V<&:U+C'$" ,78# )L+@),\0P!X[&$< &G"E!KQ#7Z,#
M1P,&D !] ,"']N!A PJ@F'>,S@ -R,$1DUBO 80#:E@!V4.@YL4NGD0"&+-
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M3&1+.]:QDON/0;H-A@SFQZQ0YLE*LMP%C9">;PO&XM R@&M)@G'<RN$4<08
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MY:.G7Q]__/OY^??WKQ\_"<KY!K8"#3Q0-7 :4(! WP+X!@(%  B@' @@,"
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M4?1:GA='Q;WKH>^#,S2BQ;"XOJ5%;XF?LYV="% M_Q.><AT-4"6) L"<W@1
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M,,0>1DBYS"$?>J,WQ@%B#: >[(&[$L <DB-B&U5#"M5C/Q9D0U9D1Y9DW4M
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M35DL8P6#F#AL_]-4V42O8!+XM,92W3%S:/G6N,ZUKG?-ZUZ3+!\]#O64<M8
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M)\HZ/'>BAB2F,3*DU"&FHB1W2L=%=9AZ3A(VXK5%H11?MU&9ECD:*<=,!N
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M5APL6!R77WPK76PK8WS%QB*5N5+&QQ+&S4+%;GPK;$S&Q*+&=,:5V'HI3I4
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M\?=N'_B$S_1KK_6&[_5][_99G_AT'_=5/PYI7_9//P!AC_>03_4# %1!;QH
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M::-%3)L15W$ @7" 0Q2\="*S:X E&I$ >\ (C/@ZSA&((MJ2!TO!GY@=D5,
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1R);LR:;LRK;LR\;L;@H( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 26, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 530,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 73.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 26, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 530,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">73.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">73.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 530,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp237978_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp237978_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp237978_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp237978_exfilingfees.htm">dp237978_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp237978_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp237978_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237978_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-015313-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-015313-xbrl.zip
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MR4= E=K7U'_\HP%'4<4B!T_'_/U.CMBE.JRZ\K#=QHWWGR$7M#==U745$P\
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:+FAT;5!+!08      0 ! $<   "$"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp237978_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-26</startDate>
            <endDate>2025-11-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">530</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">530000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">73.19</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">530000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">73.19</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">73.19</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">530000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
